Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Change-In-Working-Capital" stands at -37.53 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 09/30/2024.
Sumitomo Dainippon Pharma Co Ltd's second quarter result of -19.55 Billion JPY for the item "Change In Working Capital" represents a decrease of -12.16 percent compared to it's first quarter result.
Also, Sumitomo Dainippon Pharma Co Ltd's second quarter result of -19.55 Billion JPY for the item "Change In Working Capital" represents a decrease of -133.05 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's second quarter result of -37.53 Billion JPY for the item "Change In Working Capital" represents a decrease of -191.15 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -37.38 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -37.38 Billion Japanese Yens.
The 3 year change is -62.44 Billion Japanese Yens.
The 5 year change is -12.70 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change In Working Capital | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change In Working Capital | 486,508,953,600.00 |
![]() | AbbVie Inc - Change In Working Capital | 399,570,305,024.00 |
![]() | Roche Holding AG - Change In Working Capital | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change In Working Capital | 280,205,508,085.11 |